卖什么
Bioengineered kidneys for patients with kidney failure
商业模式拆解
工作流：什么输入变成什么输出？
Developing a stem cell-based bioengineered kidney therapy combining stem cell biology, biofabrication, fluidics and cell manufacturing.
经济账：省了什么，怎么收费？
Pre-commercial; funded by prizes and collaborations, e.g. $1M KidneyX Artificial Kidney Prize (2023) and a 2025 research collaboration with Humacyte.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2021 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.